How to Help Your Patients Find Celestone Soluspan In Stock: A Provider's Guide

Supply disruptions for Celestone Soluspan (betamethasone sodium phosphate and betamethasone acetate, 6 mg/mL) create real clinical and operational challenges for practices. When your clinic can't source the vials or a patient arrives with an unfillable prescription, having a clear action plan makes all the difference. This guide is written for clinicians and office staff managing Celestone Soluspan access issues for their patients in 2026.

Step 1: Verify the Shortage Is Actually Affecting Your Distribution Channel

Before switching all patients or overhauling your ordering process, verify the scope of the issue. Contact your primary pharmaceutical distributor (AmerisourceBergen, McKesson, Cardinal Health, or regional distributor) and request availability of:

• Celestone Soluspan (betamethasone sodium phosphate/acetate injection, 6 mg/mL, 5 mL MDV) — Organon, NDC: 0052-0432-01
• Generic betamethasone sodium phosphate and betamethasone acetate injection, 6 mg/mL — American Regent and other manufacturers

Also try placing orders through secondary distributors. Supply at regional or secondary distributors may differ significantly from your primary supplier.

Step 2: Implement a Substitution Protocol for In-Office Administration

If Celestone Soluspan is unavailable in your clinic, establish a standing substitution protocol so staff and providers have clear guidance. The most clinically validated substitutes by indication are:

• Intra-articular / soft tissue injection: Triamcinolone acetonide 10–40 mg (Kenalog or generic). Most commonly used alternative with well-established joint injection protocols.
• Intrabursal: Triamcinolone acetonide 2.5–10 mg or methylprednisolone acetate 4–30 mg depending on bursa size.
• Intramuscular (systemic): Dexamethasone sodium phosphate for rapid effect; triamcinolone acetonide IM for depot effect. Convert dose using standard equivalency ratios (betamethasone 0.6 mg ≈ dexamethasone 0.75 mg).
• Intralesional: Triamcinolone acetonide 2.5–10 mg/mL (diluted as appropriate for the lesion type and size).

Step 3: Address the Patient-Facing Pharmacy Scenario

In some workflows, patients are sent to a retail or specialty pharmacy with a written prescription before their procedure appointment. When a patient calls to say they can't fill the prescription, your office will likely be the first point of contact. A clear protocol will prevent this from becoming a time sink for staff.

Recommended workflow for unfillable patient prescriptions:

1. Direct patients to medfinder (medfinder.com). medfinder calls pharmacies near the patient and identifies which ones have the medication in stock, texting results to the patient. This requires no work from your staff.
2. Authorize generic substitution. Confirm with the prescribing provider that the generic formulation (betamethasone sodium phosphate/acetate, 6 mg/mL) may be dispensed if the brand is unavailable. This can often be noted on the original prescription or communicated to the pharmacy by fax or electronic message.
3. Consider having the medication available in-clinic. For procedures that routinely use Celestone Soluspan, stocking it in-clinic for direct administration eliminates the pharmacy-filling step entirely.

Step 4: Communicate With Patients Proactively

Patients who can't access their prescribed medication often don't understand why, and may feel anxious or misled. Proactive, clear communication goes a long way:

• Inform patients at the time of prescribing that Celestone Soluspan may be harder to find at some pharmacies and provide the medfinder option upfront.
• Explain that the generic is therapeutically equivalent if they're concerned about a substitution.
• If substituting with a different corticosteroid, explain the clinical rationale in plain language and set expectations regarding time to pain relief.

Step 5: Monitor Institutional and National Shortage Resources

Stay informed using authoritative shortage resources:

• FDA Drug Shortage Database: fda.gov/drugs/drug-safety-and-availability/drug-shortages
• ASHP Drug Shortages Resource Center: ashp.org/drug-shortages
• Your pharmacy benefit manager (PBM) or hospital pharmacy for institutional updates
• Organon's medical affairs line for direct manufacturer information on availability and expected restock timing

medfinder for Providers: A Time-Saving Tool for Your Staff

medfinder for Providers allows your practice to direct patients to a service that does the pharmacy-search work for them. Rather than having your staff call pharmacies or spending time on hold, patients submit their medication and location to medfinder, which calls pharmacies on their behalf and texts them results. This reduces the administrative burden on your office while giving patients a clear next step.

For a full overview of the shortage situation, see medfinder.com/blog/celestone-soluspan-shortage-what-providers-prescribers-need-to-know-2026. For guidance on savings programs patients may benefit from, see medfinder.com/blog/how-to-help-patients-save-money-on-celestone-soluspan-provider-guide-savings.